Both glucocentric and cardiocentric approaches are necessary for a resilient disease such as diabetes.
Caramelli, Bruno; Gualandro, Danielle Menosi.
Rev Assoc Med Bras (1992)
; 64(3): 212-213, 2018 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-29641785
Oral anti-diabetic pharmacological therapies for the treatment of women with gestational diabetes.
Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: The EXAMINE trial.
Comparative review of dipeptidyl peptidase-4 inhibitors and sulphonylureas.
Efficacy and tolerability of the new autoinjected suspension of exenatide once weekly versus exenatide twice daily in patients with type 2 diabetes.
Continuous glucose monitoring in the ICU: clinical considerations and consensus.
Relationship of glycaemic control and hypoglycaemic episodes to 4-year cardiovascular outcomes in people with type 2 diabetes starting insulin.
Effect of Glyburide vs Subcutaneous Insulin on Perinatal Complications Among Women With Gestational Diabetes: A Randomized Clinical Trial.
Safety of using real-time sensor glucose values for treatment decisions in adolescents with poorly controlled type 1 diabetes mellitus: a pilot study.
Impact of the Diabetes Inpatient Care and Education (DICE) project and the DICE Care Pathway on patient outcomes and trainee doctor's knowledge and confidence.
Cost-effectiveness of exenatide twice daily vs insulin glargine as add-on therapy to oral antidiabetic agents in patients with type 2 diabetes in China.